Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Venous Thromboembolism 1Thrombosis 1Thrombophilia 1Thromboembolism 1Small Cell Lung Carcinoma 1Sarcoma 1Pulmonary Embolism 1Multiple Myeloma 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1Esophageal Neoplasms 1Digestive System Diseases 1

Interventions

Enoxaparin 3Tinzaparin 2Saline Solution 2Heparin, Low-Molecular-Weight 2Heparin 2Gemcitabine 2Fondaparinux 2Dalteparin 2130-nm albumin-bound paclitaxel 2palbociclib 1enoxaparin sodium 1edoxaban 1apixaban 1Warfarin 1Tranexamic Acid 1Sodium Chloride 1Sodium Bicarbonate 1Rivaroxaban 1Pentetic Acid 1PEGPH20 1Minocycline 1Ketoconazole 1Fluorodeoxyglucose F18 1Fluoridation 1Estramustine 1Enzyme-Linked Immunosorbent Assay 1Doxorubicin 1Docetaxel 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Thromboembolism × enoxaparin sodium × Clear all
NCT01696760 2018-12-05

Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology

Ohio State University Comprehensive Cancer Center

Phase NA Completed
12 enrolled 6 charts
Sarcoma

Sarcoma, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡